ATE420105T1 - Attenuirte gram-negative bakterien - Google Patents

Attenuirte gram-negative bakterien

Info

Publication number
ATE420105T1
ATE420105T1 AT02290861T AT02290861T ATE420105T1 AT E420105 T1 ATE420105 T1 AT E420105T1 AT 02290861 T AT02290861 T AT 02290861T AT 02290861 T AT02290861 T AT 02290861T AT E420105 T1 ATE420105 T1 AT E420105T1
Authority
AT
Austria
Prior art keywords
gram
attenuited
bacterium
negative bacteria
mutant
Prior art date
Application number
AT02290861T
Other languages
English (en)
Inventor
Helen Rachel Crooke
Jacqueline Elizabeth Shea
Robert Graham Feldman
Sylvain Gabriel Goutebroze
Gros Francois-Xavier Le
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE420105T1 publication Critical patent/ATE420105T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT02290861T 2002-04-05 2002-04-05 Attenuirte gram-negative bakterien ATE420105T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02290861A EP1350796B1 (de) 2002-04-05 2002-04-05 Attenuirte Gram-negative Bakterien

Publications (1)

Publication Number Publication Date
ATE420105T1 true ATE420105T1 (de) 2009-01-15

Family

ID=27838168

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02290861T ATE420105T1 (de) 2002-04-05 2002-04-05 Attenuirte gram-negative bakterien
AT07018562T ATE470674T1 (de) 2002-04-05 2002-04-05 Abgeschwächte gramnegative bakterien

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT07018562T ATE470674T1 (de) 2002-04-05 2002-04-05 Abgeschwächte gramnegative bakterien

Country Status (7)

Country Link
EP (2) EP1914239B1 (de)
AT (2) ATE420105T1 (de)
CY (1) CY1108972T1 (de)
DE (2) DE60230717D1 (de)
DK (1) DK1350796T3 (de)
ES (2) ES2346915T3 (de)
PT (2) PT1914239E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449178B2 (en) 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
DE602004003582T2 (de) * 2003-07-02 2007-09-20 Biotechnology Research And Development Corp., Peoria Akapsuläre i p. multocida hyae deletionsmutanten
ATE491720T1 (de) * 2004-12-22 2011-01-15 Intervet Int Bv Impfstoff gegen pasteurella multocida
TWI328458B (en) * 2007-03-09 2010-08-11 Univ Nat Chunghsing Subunit vaccine of pasteurella multocida in veterinary uses
CL2008000856A1 (es) * 2007-03-26 2008-05-30 Wyeth Corp Uso de una pasteurella multocida mutante acapsular y atenuada para inducir inmunidad protectora cruzada en un animal contra p. multocida virulenta que tiene un serotipo diferente al de p. multocida mutante.
CN102304493B (zh) * 2011-09-14 2012-09-12 扬州大学 一株针对鸭疫里默氏杆菌的单抗
CN117229376A (zh) * 2022-09-05 2023-12-15 江苏省农业科学院 一种用于制备巴氏杆菌病疫苗的重组蛋白PlpE及其制备和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
EP0575491B1 (de) 1991-03-07 2003-08-13 Virogenetics Corporation Gentechnologisch hergestellter stamm für impfstoffe
WO1994011024A1 (en) * 1992-11-06 1994-05-26 Regents Of The University Of Minnesota Composition protective against p. multocida pasteurellosis infection
SG119177A1 (en) * 1994-12-09 2006-02-28 Imp College Innovations Ltd Identification of genes
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
TWI224107B (en) 1998-10-22 2004-11-21 Pfizer Prod Inc Novel proteins from actinobacillus pleuropneumoniae
KR20060116041A (ko) * 1999-04-09 2006-11-13 파마시아 앤드 업존 캄파니 엘엘씨 항균성 백신 조성물
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria

Also Published As

Publication number Publication date
EP1914239A1 (de) 2008-04-23
CY1108972T1 (el) 2014-07-02
DE60230717D1 (de) 2009-02-26
ES2346915T3 (es) 2010-10-21
EP1350796B1 (de) 2009-01-07
PT1350796E (pt) 2009-01-23
DK1350796T3 (da) 2009-03-02
EP1350796A1 (de) 2003-10-08
EP1914239B1 (de) 2010-06-09
ES2320419T3 (es) 2009-05-22
ATE470674T1 (de) 2010-06-15
DE60236698D1 (de) 2010-07-22
PT1914239E (pt) 2010-07-30

Similar Documents

Publication Publication Date Title
ATE518955T1 (de) Abgeschwächte gram-negative bakterien
PT721506E (pt) Proteinas exportadas bacterianas e vacinas acelulares baseadas nestas
NZ549873A (en) Compounds and methods for treatment and diagnosis of chlamydial infection by stimulating an immune response
ATE382685T1 (de) Bakteriophagen-lysin
ES2535961T3 (es) Bacteria pasteurelácea atenuada que tiene una mutación en un gen de virulencia
CY1108972T1 (el) Εξασθενημενα αρνητικα κατα gram βακτηρια
Sauerborn et al. Nucleotide sequence of Clostridium difficile toxin A
RU2005101623A (ru) Вирулентные гены, белки и их применение
ATE121754T1 (de) Vakzine gegen bordetella.
BR9506038A (pt) Dna clonato vetor recombinante e planta
ATE414156T1 (de) Lipase-varianten
TW200716166A (en) Lawsonia intracellularis immunological proteins
KR930013104A (ko) 세르풀리나 하이오다이센테리애 백신
NO20025126L (no) (R)-2-hydroksy-3-fenylpropionisk syre (D-fenylmelkesyre) dehydrogenase, oggen som koder for samme
GB9027901D0 (en) Acellular vaccine
EP0949333A4 (de) Mutierte antigene des masernvirus und die dafür kodierenden gene.
DE60021707D1 (de) Beta-primeverosidase gen
DE60135971D1 (de) Mit wt1 interagierendes protein, wtip
DK0663955T3 (da) Nucleinsyre, som koder for en alfa-acetolactat-decarboxylase, og anvendelser deraf

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1350796

Country of ref document: EP